The biomolecular corona of nanomedicines: effects on nanomedicine outcomes and emerging opportunities

Curr Opin Biotechnol. 2024 Mar 9;87:103101. doi: 10.1016/j.copbio.2024.103101. Online ahead of print.ABSTRACTUpon administration, nanomedicines adsorb a corona of endogenous biomolecules on their surface, which can affect nanomedicine interactions with cells, targeting, and efficacy. While strategies to reduce protein binding are available, the high selectivity of the adsorbed corona is enabling novel applications, such as for biomarker discovery and rare protein identification. Additionally, the adsorbed molecules can promote interactions with specific cell receptors, thus conferring the nanomedicine new endogenous targeting capabilities. This has been reported for Onpattro, a lipid nanoparticle targeting the hepatocytes via apolipoproteins in its corona. Recently, selective organ-targeting (SORT) nanoparticles have been proposed, which exploit corona-mediated interactions to deliver nanoparticles outside the liver. Strategies for corona seeding and corona engineering are emerging to increase the selectivity of similar endogenous targeting mechanisms.PMID:38461749 | DOI:10.1016/j.copbio.2024.103101
Source: Current Opinion in Biotechnology - Category: Biotechnology Authors: Source Type: research